AdAlta Ltd. (AU:1AD) has released an update.
AdAlta Limited has announced the availability of its listed options (ASX:1ADOA) for exercise at $0.03 each until the expiry date of 29 May 2024. Holders can exercise a minimum of 100,000 options through the Automic Investor Portal using various payment methods. The Melbourne-based clinical stage drug development company is known for its proprietary i-body technology, which is advancing treatments for medical conditions such as Idiopathic Pulmonary Fibrosis.
For further insights into AU:1AD stock, check out TipRanks’ Stock Analysis page.
